Genomic insights into tuberculosis

@article{Galagan2014GenomicII,
  title={Genomic insights into tuberculosis},
  author={James E. Galagan},
  journal={Nature Reviews Genetics},
  year={2014},
  volume={15},
  pages={307-320}
}
  • J. Galagan
  • Published 1 May 2014
  • Biology, Medicine
  • Nature Reviews Genetics
Prevalent since pre-history, human tuberculosis — caused by the pathogen Mycobacterium tuberculosis — remains a major source of death worldwide. Moreover, increasing drug resistance poses the threat of disease resurgence. However, the expanding application of genomic techniques is providing new avenues for combating this old foe. Whole-genome sequencing, comparative genomics and systems biology are generating new insights into the origins and ongoing evolution of M. tuberculosis, as well as the… 
The challenge of drug resistant tuberculosis
TLDR
Using a sub-cluster of strains from the London outbreak, the utility of whole genome sequencing is confirmed in understanding the pathogenesis of clinical strains, discovering specific genetic mutations that may have allowed the outbreak to persist for years.
Translating genomics research into control of tuberculosis: lessons learned and future prospects
TLDR
Major recent advances in genomics research are highlighted and the potential for genomics approaches to inform tuberculosis control efforts in high-burden settings is evaluated.
The population genomics of within-host Mycobacterium tuberculosis
TLDR
This emerging evolutionary framework involving the joint estimation of demographic, selective, and reproductive processes is forming a new paradigm for the study of within-host pathogen evolution that will be widely applicable across organisms.
Mycobacterium tuberculosis.
A Microbiological Revolution Meets an Ancient Disease: Improving the Management of Tuberculosis with Genomics
TLDR
Genomics-based methods that are positioned to be introduced in the modern clinical TB laboratory are summarized and how recent advances in genomics will improve the detection of antibiotic resistance-conferring mutations and the understanding of M. tuberculosis transmission dynamics and epidemiology are highlighted.
Immunological consequences of strain variation within the Mycobacterium tuberculosis complex
TLDR
This review highlights the studies demonstrating differences in innate and adaptive immunological outcomes consequent on MTBC genetic diversity, and discusses how these differences in immune response might influence the development of TB vaccines, diagnostics and new therapies.
Advances in the development of molecular genetic tools for Mycobacterium tuberculosis.
Diagnosing tuberculosis in the 21st century – Dawn of a genomics revolution?
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 208 REFERENCES
Genetic diversity in Mycobacterium tuberculosis.
  • S. Gagneux
  • Biology
    Current topics in microbiology and immunology
  • 2013
TLDR
Given the complexity of the host-pathogen interaction in tuberculosis, systems approaches will be key to define the role of MTBC diversity in the fight against one of humankind's most important pathogens.
Does M. tuberculosis genomic diversity explain disease diversity?
A role for systems epidemiology in tuberculosis research.
The re-emergence of tuberculosis: what have we learnt from molecular epidemiology?
  • M. Borgdorff, D. van Soolingen
  • Medicine, Biology
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2013
TLDR
Questions to be answered in the near future with whole genome sequencing include identification of chains of transmission within clusters of patients, more precise quantification of mixed infection, and transmission probabilities and rates of progression from infection to disease of various M. tuberculosis lineages, as well as possible variations in vaccine efficacy by lineage.
How can immunology contribute to the control of tuberculosis?
  • S. Kaufmann
  • Medicine, Biology
    Nature Reviews Immunology
  • 2001
TLDR
A clear understanding of the immune responses that control the pathogen will be important for achieving optimal immunity, and information provided by functional genome analysis of M. tuberculosis will be vital in the design of a future vaccine.
Tuberculosis drug resistance: a global threat.
  • J. Nachega, R. Chaisson
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2003
TLDR
Management of MDR-TB relies on prompt recognition and treatment with at least 3 drugs to which an isolate is susceptible, and an understanding of the molecular basis of drug resistance may contribute to the development of new drugs.
Variable host-pathogen compatibility in Mycobacterium tuberculosis.
TLDR
It is demonstrated that the global population structure of M. tuberculosis is defined by six phylogeographical lineages, each associated with specific, sympatric human populations, and in an urban cosmopolitan environment, mycobacterial lineages were much more likely to spread in sympatrics than in allopatric patient populations.
...
1
2
3
4
5
...